v3.25.2
Financial Instruments
9 Months Ended
Jun. 28, 2025
Financial Instruments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of June 28, 2025 and September 28, 2024 (in millions):
June 28, 2025
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$26,686 $— $— $26,686 $26,686 $— $— 
Level 1:
Money market funds3,779 — — 3,779 3,779 — — 
Mutual funds
646 134 (3)777 — 777 — 
Subtotal4,425 134 (3)4,556 3,779 777 — 
Level 2 (1):
U.S. Treasury securities15,775 46 (362)15,459 1,030 3,649 10,780 
U.S. agency securities5,383 — (189)5,194 647 2,030 2,517 
Non-U.S. government securities6,756 43 (567)6,232 297 795 5,140 
Certificates of deposit and time deposits3,177 — — 3,177 3,113 51 13 
Commercial paper710 — — 710 710 — — 
Corporate debt securities49,671 212 (1,251)48,632 11,576 37,049 
Municipal securities263 — (3)260 — 157 103 
Mortgage- and asset-backed securities23,424 90 (1,434)22,080 — 68 22,012 
Subtotal105,159 391 (3,806)101,744 5,804 18,326 77,614 
Total
$136,270 $525 $(3,809)$132,986 $36,269 $19,103 $77,614 
September 28, 2024
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Current
Marketable
Securities
Non-Current
Marketable
Securities
Cash$27,199 $— $— $27,199 $27,199 $— $— 
Level 1:
Money market funds778 — — 778 778 — — 
Mutual funds
515 105 (3)617 — 617 — 
Subtotal1,293 105 (3)1,395 778 617 — 
Level 2 (1):
U.S. Treasury securities16,150 45 (516)15,679 212 4,087 11,380 
U.S. agency securities5,431 — (272)5,159 155 703 4,301 
Non-U.S. government securities17,959 93 (484)17,568 1,158 10,810 5,600 
Certificates of deposit and time deposits873 — — 873 387 478 
Commercial paper1,066 — — 1,066 28 1,038 — 
Corporate debt securities65,622 270 (1,953)63,939 26 16,027 47,886 
Municipal securities412 — (7)405 — 190 215 
Mortgage- and asset-backed securities24,595 175 (1,403)23,367 — 1,278 22,089 
Subtotal132,108 583 (4,635)128,056 1,966 34,611 91,479 
Total (2)(3)
$160,600 $688 $(4,638)$156,650 $29,943 $35,228 $91,479 
(1)The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.
(2)As of September 28, 2024, cash and cash equivalents included $2.6 billion held in escrow and restricted from general use. These restricted cash and cash equivalents were designated to settle the Company’s obligation related to the 2016 European Commission (the “Commission”) decision that Ireland granted state aid to the Company (the “State Aid Decision”), which was confirmed during the fourth quarter of 2024 by the European Court of Justice in a reversal of the 2020 judgment of the European General Court.
(3)As of September 28, 2024, current marketable securities included $13.2 billion held in escrow and restricted from general use. These restricted marketable securities were designated to settle the Company’s obligation related to the State Aid Decision.
As of June 28, 2025, 82% of the Company’s non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, 14% between 5 and 10 years, and 4% greater than 10 years. As of June 28, 2025, 12% of the Company’s non-current mortgage- and asset-backed securities had maturities between 1 and 5 years, 11% between 5 and 10 years, and 77% greater than 10 years.
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
Foreign Exchange Rate Risk
To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of June 28, 2025, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 17 years.
The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges.
The notional amounts of the Company’s outstanding derivative instruments as of June 28, 2025 and September 28, 2024, were as follows (in millions):
June 28,
2025
September 28,
2024
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$63,212 $64,069 
Interest rate contracts$12,875 $14,575 
Derivative instruments not designated as accounting hedges:
Foreign exchange contracts$78,649 $91,493 
As of June 28, 2025 and September 28, 2024, the carrying amount of the Company’s current and non-current term debt subject to fair value hedges was $12.5 billion and $13.5 billion, respectively.
Accounts Receivable
Trade Receivables
As of June 28, 2025, the Company had two customers that individually represented 10% or more of total trade receivables, which accounted for 18% and 10%. The Company’s third-party cellular network carriers accounted for 31% and 38% of total trade receivables as of June 28, 2025 and September 28, 2024, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of June 28, 2025, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 48% and 14%. As of September 28, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 44% and 23%.